Fusion Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Fusion Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.52M, a 43.4% increase year-over-year.
  • Fusion Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $13.8M, a 21.6% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.4M, a 14.8% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.8M, a 26% increase from 2021.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.6M, a 155% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.4M +$1.6M +14.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $10.8M +$2.24M +26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $8.6M +$5.24M +155% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $3.37M +$2.75M +445% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $618K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.